From Designing their previous office in UTC when they were Jecure Therapeutics, to Design Managing their new home in Torrey Pines, 858 Therapeutics who was founded in 2019 has been a great and fun client to work with. 858 is a biotechnology and drug discovery company founded by a team of veteran drug discovery scientists. In 2021 858 Therapeutics received $60…
Intersect Management attended the grand opening and ribbon cutting of Quidel’s new building in Carlsbad, California. In attendance was the Mayor of Carlsbad Matt Hall, CEO of Quidel Doug Bryant, and Alexandria Real Estate’s Co-Chief Investment Officer & Regional Market Director Dan Ryan. Quidel’s Carlsbad location is now home to a top-quality manufacturing site…
Intersect’s Interior Designer, Assistant Project Manager, along with Mike Barbera, recently completed an interior and exterior facility redevelopment for a 50,000 square foot project in San Diego. The 2-story redevelopment included a partial re-skin of the building, plus a complete interior gut. The interior buildout included new high bay office space, spacious break room, conference…
What does it take to successfully decommission an operating cGMP manufacturing site and meet surrender plan and lease obligations in the process? Tons of coordination. When you have a manufacturing facility producing biological materials you must use extreme attention to detail and coordination, and plan, plan, plan for the facility to close safely and properly.…
